Catalyst
Slingshot members are tracking this event:
Phase 2 PFS data of OGX-427, carboplatin and pemetrexed - SpuceTrial for Non-squamous, non-small cell lung cancer (NSCLC) due 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OGXI | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 20, 2016
Occurred Source:
http://ir.oncogenex.com/releasedetail.cfm?ReleaseID=951016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Pfs, Data, Ogx-427, Carboplatin, Pemetrexed, Spucetrial, Nsclc, 1q, Apatorsen, Hsp27, Orca
